Rubius Therapeutics Inc. (RUBY) Dropped -5.3% or -0.75 To Price $13.4 On Thursday


Rubius Therapeutics Inc. (RUBY) dropped -5.3% or -0.75 to $13.4. It is around 65854 shares traded, which is 23.29% compare to the average total volume 282755. The market cap of RUBY is $1.07 billion. The year to date change is -27.12%. The 52 week price range is from $12.7 to $33.01. Price of RUBY have changed -10.50% during last week. It have changed -11.56% over last month, -14.14% over last 3 months, -33.35% over last 6 months and -41.65% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RUBY is 16.92. It is 26.27% above current price. The 200-day Moving Averages for RUBY is 17.78. It is 32.69% above current price. The 52-week High is 33.01. It is 146.34% from the current price. The 52-week Low is 12.7. It is -5.22% from current price.

There are some statistics of RUBY. It is has market cap $1.07 billion. The share outstanding is 79.93 million. The average volume is 282755. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RUBY is -39.68%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RUBY is -33.95%.


Tags:

Share this post